Skip to main content
. 2022 Aug 13;14(21):8700–8718. doi: 10.18632/aging.204226

Figure 7.

Figure 7

Validation of the efficacy of the gene model in TCGA samples. (A) CC patient distribution according to the median risk score. (B) Kaplan–Meier analysis between the low- and high-risk groups. (C) ROC analysis of the risk score. (D) The relationship between patient survival status and risk score. (E) PCA between the low- and high-risk groups.